Interactions between mitogen-activated protein kinase and protein kinase C signaling during oocyte maturation and fertilization in a marine worm.
In the marine nemertean worm Cerebratulus, follicle-free oocytes re-initiate meiosis and undergo nuclear disassembly (=germinal vesicle breakdown, GVBD) after being stimulated to mature by seawater (SW) or cAMP-elevating drugs. Previously, it has been shown that inhibitors of mitogen-activated protein kinase (MAPK) or protein kinase C (PKC) signaling can reduce SW-induced GVBD in nemertean oocytes without affecting cAMP-induced GVBD. Thus, SW and cAMP elevators may trigger alternative pathways that vary in their dependence on MAPK and PKC. To further characterize such signaling cascades, immunoblotting analyses of MAPK and PKC activities were conducted on oocytes treated with U0126, an inhibitor of the MAPK kinase (MAPKK) that is responsible for activating MAPK. Based on these analyses and comparisons with the MAPKK inhibitor CI1040 that inactivates MAPK without preventing GVBD, U0126 seems to block GVBD via a non-MAPK-mediated effect that involves PKC. Moreover, evidence is presented for post-GVBD oocytes establishing positive feedback between MAPK and PKC signaling. Such feedback apparently allows the activities of both kinases to be maintained before insemination and to undergo concomitant downregulation after fertilization. Furthermore, in oocytes treated with MAPKK and PKC inhibitors during fertilization, sperm incorporation and polar body formation still occur, but normal cleavage is prevented. This suggests that although GVBD and aspects of post-fertilization activation may proceed in the absence of MAPK or PKC, such kinases are apparently required for proper embryogenesis. Collectively, these results are discussed relative to previous analyses of the interactions and functions of MAPK and PKC signaling during oocyte maturation and fertilization.
Stricker
Stephen A
SA
Department of Biology, University of New Mexico, Albuquerque, USA. sstr@unm.edu
D000818:Animals; D002070:Butadienes / Q000494:pharmacology; D047108:Embryonic Development / Q000187:drug effects / Q000502:physiology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D005306:Fertilization / Q000187:drug effects / Q000502:physiology*; D015151:Immunoblotting; D007448:Invertebrates; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology; D009570:Nitriles / Q000494:pharmacology; D009865:Oocytes / Q000187:drug effects / Q000201:enzymology* / Q000254:growth & development*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012623:Seawater / Q000737:chemistry; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D015854:Up-Regulation
D002070:Butadienes; D009570:Nitriles; C113580:U 0126; D011493:Protein Kinase C; D048049:Extracellular Signal-Regulated MAP Kinases